Latest Pfizer Inc News
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Friday: Dell Technologies Inc., down $3.94 to $71.93. The computer and technology services provider reported discouraging third-quarter revenue. Marvell Technology Inc.,...
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
Pfizer shares sank Friday when the drugmaker said it would abandon a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it. The pharmaceutical company said it will focus instead on a once-daily version of the pill, danuglipron, instead...
NOT REAL NEWS: A look at what didn't happen this week
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: ___ No evidence that...
JetBlue, Caterpiller fall; Pinterest, AB InBev rise, Tuesday, 10/31/2023
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Tuesday: JetBlue Airways Corp., down 44 cents to $3.76. The airline reported a steeper loss for the summer months than expected. Caterpillar Inc., down $16.11 to $226.05. ...
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue. Sales of the drugmaker's COVID treatment Paxlovid and the vaccine Comirnaty slid 97% and 70%, respectively, as Pfizer, like its competitors, switched to selling on...
Pfizer: Q3 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Tuesday reported a loss of $2.38 billion in its third quarter. The New York-based company said it had a loss of 42 cents per share. Losses, adjusted for one-time gains and costs, were 17 cents per share. The...
COVID-19 treatments to enter the market with a hefty price tag
WASHINGTON (AP) — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but...
FMC, Ultra Clean fall; Textainer, EngageSmart rise, Monday, 10/23/2023
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Monday: Chevron Corp. (CVX), down $6.15 to $160.68. The energy giant is buying rival Hess in an all-stock deal valued at $53 billion. FMC Corp. (FMC), down $8.83 to...
Company bosses and workers grapple with the fallout of speaking up about the Israel-Hamas war
NEW YORK (AP) — Starbucks accused a union representing thousands of its baristas of damaging the brand and endangering co-workers with a pro-Palestinian tweet. The CEO of a prominent tech conference resigned amid backlash for his public statements suggesting that Israel was committing war crimes....
Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought
Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the...
